Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nature Cardiovascular Research is Scopus-indexed (Q1, CiteScore 15.6), WoS ESCI. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.
Checked against the index lists dated .
ISSN 2731-0590Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$12,690 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | 3 / 144 | 98th | Q1 |
| Medicine (miscellaneous) | 18 / 466 | 96th | Q1 |
| Cardiology and Cardiovascular Medicine | 16 / 409 | 96th | Q1 |
| Cell Biology | 30 / 289 | 89th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q1, CiteScore 15.6.
Nature Cardiovascular Research is Q1 in Biochemistry, Genetics and Molecular Biology (miscellaneous) (rank 3 of 144), Q1 in Medicine (miscellaneous) (rank 18 of 466) and Q1 in Cardiology and Cardiovascular Medicine (rank 16 of 409), by CiteScore 2025. It is ranked in 4 subject areas in all.
Nature Cardiovascular Research is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 15.6, which places it in quartile Q1 at the 98th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 4.767, quartile Q1, with an H-index of 39.
The publisher lists an article processing charge of about US$12,690 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Nature Cardiovascular Research is published by Springer. Its ISSN is 2731-0590.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nature Cardiovascular Research has an h-index of 58 and a 2-year mean of 7.64 citations per paper (OpenAlex). Its Scopus CiteScore is 15.6, quartile Q1. On 2-year citations it ranks #7 of 141 Scopus journals in Biochemistry, Genetics and Molecular Biology (miscellaneous).
Nature Cardiovascular Research published 179 papers in 2025; its busiest recent year was 2023 with 206. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 74 research articles (2026), authors are most often from United States (39.1%), United Kingdom (12.7%) and China (8.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.